Here we discuss the advantages and pitfalls of HIPEC in advanced ovarian cancer, as well as current data and ongoing prospective trials.
Anton Oseledchyk, MD
Advertisement
Articles by Anton Oseledchyk, MD
Advertisement
Latest Updated Articles
- Intraoperative Hyperthermic Intraperitoneal Chemotherapy in Patients With Advanced Ovarian Cancer
Published: September 15th 2015 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC
2
Lifileucel Confers Durable Responses in Pretreated Advanced NSCLC Type
3
EDIC Displays Continuous Evolution as Variable in EOT Grade 3 Lymphopenia
4
How Can Oncology Staffing Shortages Be Remedied?
5
